Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2006-02-21
2008-08-26
Salimi, Ali R. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C424S205100, C424S184100
Reexamination Certificate
active
07416732
ABSTRACT:
The invention relates to the recombinant production of proteins as well as VLPs which are suitable as a vaccine for therapeutic and prophylactic vaccination. The invention also relates to processes for the production and purification of recombinant papilloma virus proteins and fusion proteins.
REFERENCES:
patent: 5855891 (1999-01-01), Lowy et al.
patent: 6066324 (2000-05-01), Gissmann et al.
patent: 6123948 (2000-09-01), Whittle et al.
patent: 6361778 (2002-03-01), Gissmann et al.
patent: 6599508 (2003-07-01), Gissmann et al.
patent: 0565794 (1993-10-01), None
patent: WO-93/00436 (1993-01-01), None
patent: WO-93/02184 (1993-02-01), None
patent: WO-93/20844 (1993-10-01), None
patent: WO-94/00152 (1994-01-01), None
patent: WO-94/20137 (1994-09-01), None
Altmann, et al., “Towards HPV Vaccination,” in Minson A., Neil J., McCrae M. (eds): Viruses and Cancer, Cambridge University Press, pp. 71-80 (1994).
Crum, C.P., et al., Virology, Coexpression of the Human Papillomavirus Type 16 E4 and L1 Open Reading Frames in Early Cervical Neoplasia, vol. 178, pp. 238-246, 1990.
Jochmus et al., Archives of Medical Research, vol. 30, pp. 269-274, 1999.
Michel et al., Virology, vol. 294, pp. 47-59, 2002.
Nasseri, M., et al., Virology, Genetic Analysis of CRPV Pathogenesis: The L1 Open Reading Frame is Dispensable for Cellular Transformation but is Required for Papilloma Formation, vol. 170, pp. 321-325, 1989.
Wettstein, et al., “State of Viral DNA and Gene Expression in Genign VS. Malignant Tumors,” in Pfister H. (ed): Papilloma Viruses and Human Cancer, Boca Raton, 8:155-179 (1990).
Zhou, J., et al., Virology, Glycosylation of Human Papillomavirus Type 16 L1 Protein, vol. 194, pp. 210-218, 1993.
Zhou, J. et al., Virology, Identification of the Nuclear Localization Signal of Human Papillomavirus Type 16 L1 Protein, vol. 185, pp. 625-632, 1991.
Gissmann Lutz
Muller Martin
Painstil Jeanette
Zhou Jian
Loyola University of Chicago
Marshall & Gerstein & Borun LLP
Salimi Ali R.
LandOfFree
Papilloma virus-like particles, fusion proteins as well as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Papilloma virus-like particles, fusion proteins as well as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Papilloma virus-like particles, fusion proteins as well as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3999681